Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-111997
Filing Date
2012-03-13
Accepted
2012-03-13 15:58:54
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d268606d10k.htm 10-K 1233595
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUTING FIRM d268606dex231.htm EX-23.1 2402
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d268606dex311.htm EX-31.1 8541
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER d268606dex312.htm EX-31.2 8394
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d268606dex321.htm EX-32.1 8338
12 GRAPHIC g268606g73w62.jpg GRAPHIC 47467
  Complete submission text file 0001193125-12-111997.txt   3403198

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT orex-20111231.xml EX-101.INS 419661
7 XBRL TAXONOMY EXTENSION SCHEMA orex-20111231.xsd EX-101.SCH 11714
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20111231_cal.xml EX-101.CAL 30423
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20111231_def.xml EX-101.DEF 12178
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20111231_lab.xml EX-101.LAB 121791
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20111231_pre.xml EX-101.PRE 84023
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33415 | Film No.: 12687153
SIC: 2834 Pharmaceutical Preparations